Aurigene Pharmaceutical Services Header Aurigene Pharmaceutical Services Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Softigel Procaps","sponsor":"SciSparc","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"SciSparc Engages Procaps for Development and Production of CannAmide\u2122 and its SCI-110 Product Candidate","therapeuticArea":"Psychiatry\/Psychology","highestDevelopmentStatus":"Phase II","country":"COLOMBIA","productType":"Small molecule","productStatus":"Approved","date":"February 2021","url1":"","url2":"","graph1":"Psychiatry\/Psychology","graph2":"Phase II"}]

    Find Clinical Drug Pipeline Developments & Deals by Softigel Procaps

    Menu

    Softigel Procaps

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Softigel Procaps

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Colombia
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate

              Details:

              SCI-110 is an innovative proprietary combination drug candidate, formulated to treat the symptoms related to diseases of the central nervous system.

              Lead Product(s): Tetrahydrocannabinol,Palmitoylethanolamide

              Therapeutic Area: Psychiatry/Psychology Product Name: SCI-110

              Highest Development Status: Phase II Product Type: Small molecule

              Partner/Sponsor/Collaborator: SciSparc

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration February 10, 2021

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity
              AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
              Jai Radhe Sales is your partner for all your sourcing needs.
              Post Enquiry
              POST ENQUIRY